Does chronic oral anticoagulation with warfarin affect durability of endovascular aortic aneurysm exclusion in a midterm follow-up?

Journal of Endovascular Therapy

Volumn 12, Issue 1, 2005, Pages 58-65

  Biebl, Matthias ^a   Hakaim, Albert G ^a   Oldenburg, W Andrew ^a   Klocker, Josef ^a   Lau, Louis L ^a   Nauhauser, Beate ^a   McKinney, J Mark ^a   Paz Fumagalli, Ricardo ^a  

^a MAYO CLINIC   (United States)

Author keywords

Abdominal aortic aneurysm; Aneurysm rupture; Anticoagulation; Endoleak; Endovascular repair; Sac remodeling; Sac shrinkage; Secondary procedures; Survival; Warfarin

Indexed keywords

WARFARIN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM RUPTURE; ANEURYSM SURGERY; ANTICOAGULANT THERAPY; BLOOD CLOTTING; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENDOLEAK; ENDOPROSTHESIS LOOSENING; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK ASSESSMENT; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC ANEURYSM, ABDOMINAL; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROSTHESIS FAILURE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 13644256842     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1337R.1     Document Type: Review

References (31)

1. Allen EV, Barker NW, Waugh JM. A preparation from spoiled sweet clover:[3.3′-methylene-bis-(4-hydroxycoumarin)] which prolongs coagulation and prothrombin time of the blood: a clinical study. JAMA. 1942;120:1009-1015.
2. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 2001;119:8S-21S.
3. Feinberg WM, Blackshear JL, Laupacis A, et al. The prevalence of atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469-473.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983-988.
5. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (The Cardiovascular Health Study). Am J Cardiol. 1994;74:238-241.
6. Bush RL, Lin PH, Lumsden AB. Endovascular management of abdominal aortic aneurysms. J Cardiovasc Surg (Torino). 2000;44:527-534.
7. Buth J, van Marrewijk CJ, Harris PL, et al. Outcome of endovascular abdominal aortic aneurysm repair in patients with conditions considered unfit for an open procedure: a report on the EUROSTAR experience. J Vasc Surg. 2002;35:211-221.
8. Zarins CK, White RA, Schwarten D, et al. AneuRx stent graft versus open surgical repair of abdominal aortic aneurysms: multicenter prospective clinical trial. J Vasc Surg. 1999;29:292-308.
9. Criado FJ, Fairman RM, Becker GJ. Talent LPS AAA stent graft: results of a pivotal clinical trial. J Vasc Surg. 2003;37:709-715.
10. Geraghty PJ, Sicard GA. Abdominal aortic aneurysm repair in high-risk and elderly patients. J Cardiovasc Surg. 2003;44:543-547.
11. May J. Long-term outcome after aortic endovascular repair: the Sydney experience. Semin Vasc Surg. 2003;16:123-128.
12. Blum U, Voshage G, Lammer J, et al. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med. 1997;336:13-20.
13. Ouriel K. Endovascular repair of abdominal aortic aneurysms: the Cleveland Clinic experience with five different devices. Semin Vasc Surg. 2003;16:88-94.
14. Fairman RM, Carpenter J, Baum R, et al. Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. J Vasc Surg. 2002;35:679-685.
15. Torsello GB, Klenk E, Kasprzak B, et al. Rupture of abdominal aortic aneurysm previously treated by endovascular stent-graft. J Vasc Surg. 1998;28:184-187.
16. Owens WD, Felts J, Spitznagel E. ASA physical status classification: a study of consistency of ratings. Anesthesiology. 1978;49:239-249.
17. rd Report. Technical Report Series No 687. Geneva: World Health Organizations; 1983.
18. Veith FJ, Baum RA, Ohki T, et al. Nature and significance of endoleaks and endotension: summary of opinions expressed at an international conference. J Vasc Surg. 2002;35:1029-1038.
19. Schurink GW, Aarts NJ, Wilde J, et al. Endoleakage after stent-graft treatment of abdominal aneurysm: implications on pressure and imaging - an in vitro study. J Vasc Surg. 1998;28:234-241.
20. Baum RA, Carpenter JP, Cope C, et al. Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg. 2001;33:32-41.
21. Becquemin JP, Kelley L, Zubilewicz T, et al. Outcomes of secondary interventions after abdominal aortic aneurysm endovascular repair. J Vasc Surg. 2004;39:298-305.
22. Sampram ES, Karafa MT, Mascha EJ, et al. Nature, frequency, and predictors of secondary procedures after endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2003;37:930-937.
23. Lin E, Galvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000; 127:117-26.
24. Swartbol P, Truedsson L, Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2001;21:393-400.
25. van Marrewijk CJ, Fransen G, Laheij RJ, et al. Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up. Eur J Vasc Endovasc Surg. 2004;27:127-137.
26. Chuter TA, Reilly LM, Faruqi RM, et al. Endovascular aneurysm repair in high-risk patients. J Vasc Surg. 2000;31:122-133.
27. Tureff SN, Rockman CB, Lamparello PJ, et al. Are type II (branch vessel) endoleaks really benign? Ann Vasc Surg. 2002;16:50-54.
28. van Marrewijk C, Buth J, Harris PL, et al. Significant of endoleaks after endovascular repair of abdominal aortic aneurysm: the EUROSTAR experience. J Vasc Surg. 2002;35:461-473.
29. Steinmetz E, Rubin BG, Sanchez LA, et al. Type II endoleak after endovascular abdominal aortic aneurysm repair: a conservative approach with selective intervention is safe and cost-effective. J Vasc Surg. 2004;39:306-313.
30. Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest. 1989;95(Suppl):107S-117S.
31. Flinn WR, Rohrer MJ, Yao JS, et al. Improved long-term patency of infragenicular polytetrafluoroethylene grafts. J Vasc Surg. 1988;7:685-690.